FDA approves 1st new gonorrhea drug in decades
Digest more
FDA to put most serious warning on COVID-19 vaccines
Digest more
Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and toddlers from RSV, the respiratory virus that sends thousands of American children to the hospital each year.
Today, the U.S. Food and Drug Administration conditionally approved Exzolt Cattle-CA1 (fluralaner) topical solution for the prevention and treatment of New World screwworm (NWS) larval infestations, and the treatment and control of cattle fever tick in
Long Island Press on MSN
The breakthrough drug transforming HIV prevention: FDA-approved lenacapavir protects with twice-yearly injections
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS.
The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application.
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary Robert F. Kennedy Jr.
Ophirex announced that varespladib, which is also being developed as an oral rescue treatment for snakebite envenomation in dogs, has received MUMS designation for minor use in a major species from the FDA Center for Veterinary Medicine for the treatment of snakebite in dogs.